Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  VBI Vaccines Inc.    VBIV   CA91822J1030

VBI VACCINES INC.

(VBIV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • The share is getting closer to its long-term support in weekly data, at USD 2.07, which offers good timing for buyers.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the USD 1.16 support.
  • The prospective high growth for the next fiscal years is among the main assets of the company
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 2.07 USD
Weaknesses
  • Low profitability weakens the company.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The company's earnings releases usually do not meet expectations.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Ratings chart
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalisation (M$)Investor Rating
VBI VACCINES INC.84.78%590
LONZA GROUP AG62.80%47 152
SEAGEN INC.72.54%34 263
IQVIA HOLDINGS INC.8.39%32 108
CELLTRION, INC.31.49%28 160
MODERNA, INC.260.58%27 830
IMMUNOMEDICS, INC.315.22%20 324
INCYTE CORPORATION2.71%19 615
ALNYLAM PHARMACEUTICALS, IN..14.47%15 289
HANGZHOU TIGERMED CONSULTIN..81.98%14 842
PHARMARON BEIJING CO., LTD.109.72%12 414
PPD, INC.0.00%12 368
CHARLES RIVER LABORATORIES ..52.40%11 566
QIAGEN N.V.47.37%11 394
BIO-TECHNE CORPORATION22.30%10 351
ICON PUBLIC LIMITED COMPANY12.84%10 257
More Results
Financials (USD)
Sales 2020 1,31 M - -
Net income 2020 -38,2 M - -
Net Debt 2020 - - -
P/E ratio 2020 -14,0x
Yield 2020 -
Capitalization 590 M 590 M -
Capi. / Sales 2020 451x
Capi. / Sales 2021 87,8x
Nbr of Employees 124
Free-Float 72,5%
Upcoming event on VBI VACCINES INC.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes